Schedule a call →

<p>Interview fractional leaders this week for <strong>free</strong>!</p>

SeraNovo

SeraNovo is a pharmaceutical formulation company focused on increasing oral bioavailability of poorly soluble APIs using deep eutectic solvent technology.

SeraNovo Icon

SeraNovo is a drug formulation company specializing in oral drug delivery and bioavailability enhancement for poorly soluble and complex compounds.We partner with biotech and pharmaceutical companies to solve one of the most critical challenges in drug development: enabling molecules to achieve sufficient solubility, absorption, and in vivo exposure.As drug candidates become increasingly complex, including beyond Rule of 5 (bRo5) compounds, protein degraders, and peptides, formulation and delivery limitations have become a major bottleneck. SeraNovo addresses these challenges at the source.Our proprietary NanoGlassTM technology generates and stabilizes amorphous drug nanoparticles in situ, improving dissolution and oral absorption while maintaining the stability and scalability required for development.Founded in 2017 and based in Leiden, the Netherlands, SeraNovo has successfully addressed difficult formulation challenges for a diverse, global client base, helping to advance promising medical therapies toward clinical success.Based in Leiden, Netherlands, SeraNovo works with global biotech and pharmaceutical partners to advance drug candidates from molecule to viable therapy.Our goal: to become the go-to formulation company for oral drug delivery and bioavailability challenges and ensure no promising drug fails due to formulation limitations.

Research

Business Development

Consulting

Operations

Human Resources

Information Technology

Netherlands

The Randstad, Netherlands

South Holland, Netherlands

Leiden

Rotterdam

Amsterdam Area

Rotterdam and The Hague

North Holland, Netherlands

Haarlem

Tilburg

Hoofddorp

United States

SeraNovo is a pharmaceutical formulation company that specializes in increasing the oral bioavailability of poorly soluble APIs (Active Pharmaceutical Ingredients) using their innovative deep eutectic solvent technology. With a focus on enhancing bioavailability and reducing development time to the clinic, SeraNovo is dedicated to solving these critical issues in drug development. Their state-of-the-art proprietary eutectic formulation technology is a proven approach that significantly enhances the bioavailability of even the most difficult to formulate APIs. What sets SeraNovo apart is their rapid formulation development, combining API modeling with high throughput development processes to create the optimum formulation(s) in the shortest possible time. SeraNovo's manufacturing operations are simple and efficient, involving only gentle heating and stirring. This allows for easy transfer and rapid upscaling of the clinical formulation. Additionally, SeraNovo ensures the safety of their formulations by utilizing only safe excipients, carefully selected to enable higher exposure during toxicology studies or for moving a product into the clinic. For more information about SeraNovo and their cutting-edge formulation platforms and services, visit their website or contact them via email.

Chemical Industry

Heavy Industry and Engineering

montserrat

Bahnschrift Light

twitter

linkedin

SeraNovo Logo

Our company operates in the pharmaceutical technology industry, focusing on enhancing drug formulation and delivery solutions. Our mission is to advance the bioavailability of medications to improve patient outcomes through innovative technology platforms.

The company seeks a highly experienced Business Development professional to support its US commercial expansion on a fractional basis. This opportunity is ideal for a senior industry leader looking for a flexible, part-time engagement where they can leverage their established network to make a significant impact. The organization is renowned for enabling breakthrough oral bioavailability for poorly soluble small molecules through its innovative platform.

**Responsibilities**

*   Leverage an existing professional network to introduce the company to relevant R&D, DMPK, formulation, or external innovation teams.
*   Set up qualified business development meetings for the company’s leadership and technical teams.
*   Identify where the company’s technologies align with pipeline or formulation challenges.
*   Optionally provide a high-level explanation of the technology based on prior industry experience.
*   Maintain concise, high-level reporting of introductions and outreach progress.

**Qualifications**

*   **Location:** US-based (East or West Coast).
*   **Experience:** 15+ years in drug product development, formulation, drug delivery, CDMO services, or related fields.
*   **Network:** Strong, warm relationships across pharma and biotech sectors, with an ability to quickly open doors.
*   **Availability:** Fractional commitment of approximately 1–3 days per week, with flexible timing.
*   **Strengths:** Expert relationship-builder, credible communicator who is proactive and self-directed.
*   **Bonus:** Capability to articulate formulation or bioavailability concepts (not essential).

**What the Company Offers**

*   Competitive fractional compensation.
*   Flexible engagement structured around your availability.
*   Opportunity to support a fast-growing, science-led company that partners with multiple top-10 pharma organizations.
*   Focused role where your network, experience, and ability to create meaningful introductions provide the greatest value.

Fractional Business Development

Director of Business Development

Senior Sales Leader

Early Team

Pharmaceutical

Fractional Business Development Lead to drive US commercial expansion and leverage industry network for pharmaceutical tech company

Fractional Business Development Lead (US-Based)

Sales

SeraNovo

About SeraNovo

Funding & revenue at SeraNovo

Investors

Growth signals

Headcount change

Team composition

By function

By region

Inside SeraNovo

Categories

Markets

Jobs

Past roles